MLchartDataset catalogue

ALVAC(2) melanoma multi-antigen vaccine

Term · Oncology and biomedicine · MLC-T-ONC-010003

A therapeutic cancer vaccine, based on a replication-defective recombinant canarypox virus (ALVAC) encoding multiple melanoma antigens, with potential immunostimulatory and antineoplastic activities. Vaccination with ALVAC(2) melanoma multi-antigen therapeutic vaccine may stimulate the host immune system to mount an immune response against antigen-expressing melanoma cells, resulting in inhibition of tumor growth and/or metastasis.

Table 1. Record
IdentifierMLC-T-ONC-010003
FieldOncology and biomedicine
SynonymsALVAC(2) melanoma multi-antigen therapeutic vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-010003",
  "term": "ALVAC(2) melanoma multi-antigen vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A therapeutic cancer vaccine, based on a replication-defective recombinant canarypox virus (ALVAC) encoding multiple melanoma antigens, with potential immunostimulatory and antineoplastic activities. Vaccination with ALVAC(2) melanoma multi-antigen therapeutic vaccine may stimulate the host immune system to mount an immune response against antigen-expressing melanoma cells, resulting in inhibition of tumor growth and/or metastasis.",
  "synonyms": [
    "ALVAC(2) melanoma multi-antigen therapeutic vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/alvac-2-melanoma-multi-antigen-vaccine/"
}

Record 918 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.